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concluding remarks
Given the scarcity of effective treat-
ment options available for patients with 
advanced melanoma, the dawn of nano-
particle delivery systems could not come 
at a better time. Future studies in the field 
should focus on potential com binations 
of siRNA- and chemotherapeutic/ phar-
macological inhibitor-containing nano-
particles because both formulations have 
been shown to increase delivery and 
effectivenesss. In addition, although syn-
geneic mouse models such as B16F10 
are highly important in the development 
of cancer therapies, it would be advanta-
geous to extend these studies into mod-
els more relevant to human melanoma 
progression. Specifically, the recent 
conditional B-RAFV600E/PTEN-deficient 
metastatic melanoma mouse is an ideal 
disease model for preclinical studies 
of these nanoparticles (Dankort et al., 
2009). Additional studies with human 
melanoma xenograft mice, which allow 
for representation of a wide range of mel-
anoma genetic backgrounds and staging, 
would also be of value.
In conclusion, increasing evidence 
from the past several years has revealed 
nanoparticles to have the potential to 
improve the efficacy of current treat-
ments and/or to open doors to strategies 
such as siRNA targeting, which until now 
have been plagued with problems. The 
work of Chen et al. (2010) extends this 
area of research and demonstrates that 
targeting melanoma tumor cells with 
c-Myc siRNA packaged within the new 
DSAA nanoparticle, alone or in combi-
nation with chemotherapy, can inhibit 
melanoma tumor growth in several sys-
tems, offering hope for the development 
of potent and efficacious treatment strat-
egies for advanced melanoma.
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Oxygenation State as a Driver  
of Myofibroblast Differentiation  
and Wound Contraction:  
Hypoxia Impairs Wound Closure
Chandan K. Sen1 and Sashwati Roy1
Myofibroblasts are ubiquitous in the human body and may form from the 
differentiation of fibroblasts, epithelial cells, endothelial cells, and mononuclear 
cells, among others. Their clinical significance could be substantial, depending on 
biomedical context. Myofibroblasts help contract open skin wounds, but they could 
also be key drivers of fibrosis across numerous tissue systems and support tumor 
invasiveness. Understanding the molecular events underlying myofibroblast forma-
tion is significant for many human diseases. In this issue, Modarressi et al. address the 
significance of wound tissue hypoxia in impairing wound contraction by compro-
mising myofibroblast formation. They present compelling evidence indicating tissue 
hypoxia conflicts with wound closure. We are reminded that correcting wound tis-
sue hypoxia is critical for the tissue’s response to other therapeutic interventions.
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In 1977, Packer reported that human 
diploid fibroblasts grown at 10% O2 live 
longer than cells grown at the routine 
20% O2 (Packer and Fuehr, 1977). The 
field of cellular senescence was in its 
infancy, with the concept of the “Hayflick 
limit” reported in 1961. In 2003, Roy et 
al. (2003a) reported that growth arrest 
of fibroblasts caused by 20% O2 was 
reversible, consistent with the current 
study (Modarressi et al., 2010), and it 
was therefore concluded that exposure of 
cells to hyperoxic insult causes differen-
tiation, but not senescence. Although it 
is standard practice to culture cells at an 
ambient O2 concentration of 20% (i.e., 
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room air balanced with 5% CO2), which 
corresponds to a pO2 of approximately 
140 mm Hg at sea level, cells within the 
human body are exposed to much lower 
concentrations, ranging from about 14% 
(100 mm Hg) in pulmonary alveoli to 
3–5% (35 mm Hg) in the heart and skin 
(Roy et al., 2003a; Sen et al., 2006). Thus, 
it is important to recognize that standard 
cell culture under conditions of 20% O2 
represents exposure of cells to potential-
ly hyperoxic insult, particularly for pri-
mary cells that have been freshly isolated 
from organs and adjusted to lower pO2 
as their physiological normoxic status 
(Roy et al., 2003a; Sen et al., 2006). For 
cell lines cultured at 20% O2 over a long 
period of time, it is reasonable to assume 
that the overall cell population repre-
sents a hyperoxia-tolerant variety that has 
survived hyperoxic insult over time by 
accepting 20% O2 as a normoxic state. 
Although 20% O2 then is normoxia for 
these cells, it is important to appreciate 
that this state may little resemble the state 
of cells or cellular responses in vivo.
How do cells alter their normoxic set 
point? Cellular O2 sensing enables physi-
ological adjustments to variations in tis-
sue pO2. Under basal conditions, cells 
are adjusted to an O2 environment bio-
logically read as normoxia (Khanna et 
al., 2006). A sharp departure from that 
state triggers an O2-sensitive biological 
response. The stabilization of hypoxia-
inducible factor (HIF) signifies a robust 
biological readout of hypoxia. In the 
presence of sufficient O2, HIF is hydroxy-
lated and degraded. HIF prolyl hydroxy-
lation is catalyzed by prolyl hydroxylase 
(PHD) isoenzymes PHD1, -2, and -3. 
Using cells stably transfected with an HIF 
reporter construct, the hypothesis that 
biological cells are capable of resetting 
their normoxic set point by O2-sensitive 
changes in PHD expression has been 
tested (Khanna et al., 2006). Exposure of 
a cell line adjusted to growing in 20% O2 
to 5% O2 resulted in HIF-driven transac-
tivation. However, the same cells adjust-
ed to growing in 5%O2 did not report 
hypoxia as read by HIF transactivation.
Notably, cells adjusted to growing in 
30% O2 reported hypoxia when acutely 
exposed to room air (20% O2) culture 
conditions. When grown under elevated 
O2 conditions, cells reset their normoxic 
set point upward by downregulating the 
expression of PHDs. When grown under 
low O2 conditions, cells reset their nor-
moxic set point downward by induc-
ing the expression of PHDs. Exposure of 
mice in vivo to a hypoxic 10% O2 envi-
ronment lowered blood and brain pO2. 
Such hypoxic exposure induced PHDs. 
Exposure of mice to a hyperoxic 50% 
O2 ambience repressed the expression of 
PHD1–3, indicating that O2-sensitive reg-
ulation of PHD expression is also effective 
in vivo. Studies employing knockdown of 
PHD expression reveal that O2-sensitive 
regulation of PHD may contribute to tun-
ing the normoxic set point in biological 
cells (Khanna et al., 2006).
The state of tissue oxygenation is a 
major microenvironmental cue that 
is read by cells, integrated with other 
microenvironmental cues as a tissue 
responds to an extracellular signal. 
Although hypoxia has been studied 
extensively in the context of cell signal-
ing, hyperoxia has been studied mostly 
in the context of oxygen toxicity. Both in 
vitro and in vivo studies with fibroblasts 
have revealed that hyperoxia may be 
a potent inducer of myofibroblast dif-
ferentiation by turning on specific cell 
signaling events (Kuhn et al., 2007; Roy 
et al., 2003a,b, 2007, 2010; Sen et al., 
2006). In fibroblasts, hyperoxic insult 
causes growth arrest at the G2/M phase. 
This arrest is accompanied by induced 
expression of vimentin and α-smooth 
muscle actin, as well as by increased 
cellular contractility in a collagen 
matrix (Roy et al., 2003a). Hyperoxia 
also enhances the stability of both 
Acta2 transcript and α-smooth muscle 
actin protein (Roy et al., 2007). The 
morphological/cytoskeletal characteris-
tics of fibroblasts observed in response 
to hyperoxic exposure match those of 
fibroblasts cultured at normoxia but 
treated with transforming growth factor 
β1 (TGF-β1), a classical inducer of fibro-
blast differentiation to myofibroblasts.
Interestingly, both hyperoxia and 
TGF-β signal through p38MAPK to 
cause fibroblast differentiation (Roy et 
al., 2003a). In addition, TGF-β activation 
may be caused by hyperoxia-induced 
oxidation of the latency-associated 
peptide. Thus, hyperoxia may not only 
signal through the TGF-β pathway but 
also accentuate TGF-β signaling. Recent 
studies further support this relationship 
by demonstrating that in fibroblasts all 
three isoforms of TGF-β are induced by 
hyperoxia (Roy et al., 2010). Deletion 
of any one or both of the activating pro-
tein-1 (AP-1) binding sites in the TGF-β 
reporter construct results in a loss of O2 
sensitivity, demonstrating that AP-1 con-
fers O2 sensitivity to TGF-β transcription. 
Fos-related AP-1 transcription factor 
(Fra-2) and apoptosis signal-regulating 
kinase-1 (Ask-1) have been identified 
as key mediators of AP-1-dependent 
hyperoxia-sensitive TGF-β transcription. 
Knockdown of Fra-2 significantly blunt-
ed hyperoxia-induced expression of 
TGF-β1 as well as TGF-β3 in fibroblasts 
(Roy et al., 2010). Knockdown of Ask-1 
blunted hyper oxia-induced Fra-2 gene 
expression and nuclear localization in 
fibroblasts. These observations point 
toward a central role of Ask-1 and Fra-2 
in hyperoxia-inducible AP-1 activation 
and induction of TGF-β.
Transcriptome-wide profiling studies 
have identified hyperoxia-sensitive genes 
in fibroblasts and clustered them into 
functional groups (Roy et al., 2003b). 
The p21–p53 axis has emerged as a key 
hyperoxia-inducible pathway in fibro-
blasts. Both p21 deficiency and knock-
down blunt hyperoxia-induced Acta2 and 
smooth muscle actin expression. In vivo, 
reoxygenation-induced upregulation of 
Acta2 is abrogated completely in p21-
deficient mice. Strikingly, overexpression 
of p21 alone induces differentiation of 
fibroblasts markedly under normoxic 
basal conditions. Overexpression of p21 
alone induced transcription of α-smooth 
muscle actin by downregulating YB1 
independent of TGF-β1. Thus, studies 
aimed at understanding the significance 
of O2 tension have discovered p21 as a 
key signaling mediator that regulates the 
differentiation of fibroblasts to myofibro-
blasts (Roy et al., 2003a, 2010).
The observations of Modarressi et al. 
(2010, this issue) establish a key role for 
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 Correction of wound 
hypoxia is required 
before tissues can 
respond to therapeutic 
interventions.
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O2 tension in driving wound contraction. 
A crucial contribution of this work is 
the demonstration that under hypoxic 
conditions compromised myofibroblast 
contraction is preceded by α-smooth 
muscle actin disassembly from stress 
fibers. Consistent with previous reports 
that the effects of changing O2 tension 
on fibroblast differentiation are revers-
ible (Roy et al., 2003a), Modarressi et 
al. demonstrate that the negative effects 
of hypoxia on fibroblast differentiation 
may be corrected by restoring normox-
ia. Interestingly, Modarressi et al. (2010) 
identify a facilitatory effect of mechani-
cal stimulation in driving fibroblast 
differentiation; this effect was most pro-
nounced under conditions of high oxy-
genation. This observation is relevant to 
negative pressure wound therapy, which 
involves mechanical stimulation and 
during which improved tissue oxygen-
ation is followed by improved wound 
closure (Vikatmaa et al., 2008).
The wound literature is often con-
fusing in terms of the net impact of 
hypoxia on wound closure (Sen, 2009). 
The abundance of literature (primarily 
related to tumor biology) demonstrating 
that hypoxia is a cue for angiogenesis 
has led many to erroneously conclude 
that hypoxia may be helpful for cutane-
ous wound healing. However, from a 
clinical standpoint we know that this is 
unlikely, because ischemic wounds are 
clearly hypoxic, yet refractory to clo-
sure. Acutely, hypoxia may help gener-
ate growth and repair factors necessary 
to lay the foundation for wound closure. 
However, unless there is sufficient oxy-
gen (Sen, 2009), a good foundation for 
healing will not lead to closure. HIF-
dependent hypoxia-inducible microRNA 
miR210 impairs wound epithelialization, 
a key aspect of overall wound closure 
(Biswas et al., 2010). Therefore, although 
stabilization of HIF may elicit angiogenic 
responses, the ultimate effect is to oppose 
wound closure by stalling wound re-epi-
thelialization. The work by Modarressi et 
al. (2010) represents an important con-
tribution to the field of wound healing, 
in which compelling evidence supports 
tissue hypoxia’s conflict with wound clo-
sure. We are reminded that correction 
of wound tissue hypoxia is critical for 
wound tissue to respond to other thera-
peutic interventions.
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Lucky number Seven:  
Rnase 7 Can Prevent Staphylococcus 
aureus Skin Colonization
John S. Cho1, Caiyun Xuan1 and Lloyd S. Miller1
Staphylococcus aureus colonization is a major risk factor for infection. In this 
issue, Simanski et al. demonstrate that the antimicrobial peptide Rnase 7 is 
essential for preventing S. aureus colonization in human skin. These findings 
suggest that therapeutic interventions aimed at targeting Rnase 7 production in 
the skin may be a novel strategy to protect against S. aureus infections.
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antimicrobial peptides and  
skin host defense
Human skin presents both a physical 
and an immunological barrier against 
invading microbial pathogens. In 
addition to contributing to the physical 
barrier, the stratum corneum contains 
antimicrobial peptides that act as a 
first line of defense against pathogenic 
microbial colonization and infection 
by pathogens such as bacteria, fungi, 
and viruses (Lai and Gallo, 2009). 
